HT
ATNM icon

HAP Trading’s Actinium Pharmaceuticals ATNM Stock Holding History

HAP Trading’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,700
Closed -$8K – 1509
2022
Q3 		$8K Sell
10,700
-8,600
-45% -$53.5K ﹤0.01% 1364
2022
Q2 		$6K Sell
19,300
-31,900
-62% -$181K ﹤0.01% 1578
2022
Q1 		$16K Buy
51,200
+12,300
+32% +$64.8K ﹤0.01% 1646
2021
Q4 		$27K Buy
38,900
+7,800
+25% +$58.5K ﹤0.01% 1705
2021
Q3 		$43K Buy
31,100
+11,100
+56% +$77.2K ﹤0.01% 1551
2021
Q2 		$10K Sell
20,000
-5,100
-20% -$40K ﹤0.01% 1988
2021
Q1 		$27K Buy
+25,100
New +$213K ﹤0.01% 1356

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return